Pancreas Center Names New Co-Director, Gulam Manji, MD

Drs Gulam Manji and John Chabot

We are proud to announce that Gulam Manji, MD, PhD has been named Co-Director of The Pancreas Center. He joins founder, John Chabot, MD.

Dr. Manji is an Associate Professor of Medicine, Director of Gastrointestinal Medical Oncology, and co-leader of the Precision Oncology and Systems Biology program within the Herbert Irving Comprehensive Cancer Center. He joined the Hematology and Oncology Fellowship Program at Columbia University to pursue his interest in bench to bed side research understanding the role of the tumor immune microenvironment in cancer, with a particular focus in pancreas cancer. Dr. Manji’s research has led to six investigator-initiated multicenter clinical trials in sarcoma, gastrointestinal, and pancreatic cancers. His laboratory research, in collaboration with Dr. Kenneth Olive, targeting the immunosuppressive CXCR4-CXCL12 pathway in pancreatic cancer received the Young Investigator Award from the American Society of Clinical Oncology and led to the pilot clinical trial in stage IV pancreatic cancer which he leads. Encouraging results from the pilot trial have led to activation of a randomized phase 2 multicenter investigator initiated clinical trial. He is a key opinion leader in pancreas cancer and serves as a member on multiple national committees, including the National Cancer Institute Pancreas Task Force. Dr. Manji's research career in identifying new genes and their implication in disease and overseeing clinical trials have led to numerous key publications and an issued patent. Dr. Manji is a co-Principal investigator of multiple NIH funded grants (R01 and U01). He remains committed to bringing novel promising agents from the laboratory to the clinic in hopes to improve the clinical outcome in pancreatic cancer.

Join me in congratulating Dr. Manji in his new role as Co-Director of The Pancreas Center!